Picture of Lucira Health logo

LHDXQ — Lucira Health News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

Brief: Lucira Says Its At Home Molecular Tests Can Detect Omicron Variant

Nov 29 (Reuters) - Lucira Health Inc  LHDX.O :
    * LUCIRA'S AT HOME MOLECULAR TESTS CAN DETECT OMICRON
(B.1.1.529)
SARS COV-2 VARIANT OF CONCERN
    * LUCIRA - CONFIRMS COVID-19 CHECK-IT (OTC) AND ALL-IN-ONE
(RX)
MOLECULAR SELF-TEST KITS' ABILITY TO DETECT 100% OF OMICRON
VARIANT GENOME SEQUENCES ANALYZED
    * LUCIRA HEALTH - LUCIRA ASSAYS TARGET VIRAL SEQUENCE
REGIONS
UNAFFECTED BY SPIKE PROTEIN MUTATIONS FOUND IN OMICRON, DELTA
AND OTHER VARIANTS OF CONCERN

Source text for Eikon:  ID:nGNXG2dLt 
Further company coverage:  LHDX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lucira Health

See all news